Dicerna Pharmaceuticals Net Income Per Employee vs Invested Capital Analysis

DRNA -- USA Stock  

Earning Report: November 4, 2019  

Dicerna Pharmaceuticals financial indicator trend analysis is much more than just examining Dicerna Pharmaceuticals latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Dicerna Pharmaceuticals is a good investment. Please check the relationship between Dicerna Pharmaceuticals Net Income Per Employee and its Invested Capital accounts. Additionally see Investing Opportunities.

Net Income Per Employee vs Invested Capital

Accounts Relationship

Net Income Per Employee vs Invested Capital

Significance: Strong Relationship

Net Income Per Employee diversification synergy
Overlapping area represents amount of trend that can be explained by analyzing historical patterns of Dicerna Pharmaceuticals Net Income Per Employee account and Invested Capital

Correlation Coefficient

0.78
Relationship DirectionPositive 
Relationship StrengthSignificant

Net Income Per Employee

Invested Capital

Invested capital represents the total cash investment that shareholders and debt holders have contributed to Dicerna Pharmaceuticals. There are two different methods for calculating Dicerna Pharmaceuticals invested capital: operating approach and financing approach. Understanding ##company1# invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed. Invested capital is an input into the calculation of Return on Invested Capital; and is calculated as: [Debt] plus [Assets] minus [Intangibles] minus [CashnEq] minus [LiabilitiesC]. Please note this calculation method is subject to change.
Search macroaxis.com